Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bespak Europe Ltd Company Overview 4
Bespak Europe Ltd Company Snapshot 4
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd – Pipeline Analysis Overview 6
Bespak Europe Ltd – Key Facts 6
Bespak Europe Ltd – Major Products and Services 7
Bespak Europe Ltd Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Overview 10
Bolus Drug Delivery Device 10
Bolus Drug Delivery Device Product Overview 10
DEV610 DPI 11
DEV610 DPI Product Overview 11
IDC300 Integrated Dose Counter 12
IDC300 Integrated Dose Counter Product Overview 12
NAS010 13
NAS010 Product Overview 13
NAS020 – Unidose Nasal Drug Delivery Device 14
NAS020 – Unidose Nasal Drug Delivery Device Product Overview 14
NAS030 Nasal Device 15
NAS030 Nasal Device Product Overview 15
OCU050 Ophthalmic Drug Delivery Device 16
OCU050 Ophthalmic Drug Delivery Device Product Overview 16
VAL020 Metered Dose Inhaler Valve 17
VAL020 Metered Dose Inhaler Valve Product Overview 17
VAL050 pMDI Valve / Actuator 18
VAL050 pMDI Valve / Actuator Product Overview 18
VAL310 Easifill Valve 19
VAL310 Easifill Valve Product Overview 19
Bespak Europe Ltd – Key Competitors 20
Bespak Europe Ltd – Key Employees 21
Bespak Europe Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Bespak Europe Ltd, Recent Developments 23
Oct 17, 2016: Bespak Launches Syrina AR 2.25 Auto-injector For Fully-automatic Delivery Of Viscous Drug Formulations 23
Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 23
Jun 16, 2016: Consort Medical Provides Update on DEV610 development programme 23
Oct 08, 2015: Consort Medical Launches New Brand Identity To The Market 24
Oct 08, 2015: Bespak Launches New Brand Identity To The Market 24
Feb 11, 2015: Bespak Launches Syrina 2.25 At PDA Europe 25
Nov 28, 2013: Major long-term commercial supply contract award – dry powder inhaler 25
Sep 02, 2013: Consort Medical Issues its Interim Management Statement 26
Jul 23, 2013: Bespak Receives Contract To Develop Nasal Drug Delivery Device 26
Jul 22, 2013: Bespak development contract award 26
Appendix 27
Methodology 27
About GlobalData 30
Contact Us 30
Disclaimer 30
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Indication 5
Bespak Europe Ltd, Key Facts 6
Bespak Europe Ltd, Major Products and Services 7
Bespak Europe Ltd Number of Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Summary by Development Stage 9
Bolus Drug Delivery Device - Product Status 10
Bolus Drug Delivery Device - Product Description 10
DEV610 DPI - Product Status 11
DEV610 DPI - Product Description 11
IDC300 Integrated Dose Counter - Product Status 12
IDC300 Integrated Dose Counter - Product Description 12
NAS010 - Product Status 13
NAS010 - Product Description 13
NAS020 - Unidose Nasal Drug Delivery Device - Product Status 14
NAS020 - Unidose Nasal Drug Delivery Device - Product Description 14
NAS030 Nasal Device - Product Status 15
NAS030 Nasal Device - Product Description 15
OCU050 Ophthalmic Drug Delivery Device - Product Status 16
OCU050 Ophthalmic Drug Delivery Device - Product Description 16
VAL020 Metered Dose Inhaler Valve - Product Status 17
VAL020 Metered Dose Inhaler Valve - Product Description 17
VAL050 pMDI Valve / Actuator - Product Status 18
VAL050 pMDI Valve / Actuator - Product Description 18
VAL310 Easifill Valve - Product Status 19
VAL310 Easifill Valve - Product Description 19
Bespak Europe Ltd, Key Employees 21
Bespak Europe Ltd, Other Locations 22
Glossary 29
List of Figures
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Development Stage 8